Pavonine Co., Ltd. (KOSDAQ:177830)
3,095.00
+135.00 (4.56%)
At close: Jan 26, 2026
Pavonine Revenue
Pavonine had revenue of 33.84B KRW in the quarter ending September 30, 2025, a decrease of -3.52%. This brings the company's revenue in the last twelve months to 134.44B, up 5.83% year-over-year. In the year 2024, Pavonine had annual revenue of 132.83B with 10.06% growth.
Revenue (ttm)
134.44B
Revenue Growth
+5.83%
P/S Ratio
0.25
Revenue / Employee
574.53M
Employees
234
Market Cap
33.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 132.83B | 12.14B | 10.06% |
| Dec 31, 2023 | 120.68B | 2.65B | 2.24% |
| Dec 31, 2022 | 118.04B | -8.23B | -6.52% |
| Dec 31, 2021 | 126.26B | -2.55B | -1.98% |
| Dec 31, 2020 | 128.81B | 25.20B | 24.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| System and Application Technologies | 158.35B |
| NBT Inc. | 95.40B |
| ITEYES | 88.28B |
| Mohenz.Co.,Ltd. | 85.48B |
| TKG Aikang | 59.68B |
| Seoul Pharma | 52.43B |
| MediaZen | 13.83B |
| Nexa Dynamics | 13.22B |